Although the expression of HES1 and DLL3, which are components of the Notch signaling pathway, was shown to correlate with shorter post recurrence survival in patients with metastatic melanoma, to the best of our knowledge, no other studies have investigated the prognostic value of Notch in primary melanomas [11]. This evidence concerns the gene HES1 and melanoma.